Synthetic opioids, predominantly fentanyl, killed 72,776 Americans in 2023 and 47,735 in 2024. Those are single-year figures. Over the past decade, fentanyl has been responsible for well over 400,000 deaths in the United States, making it the deadliest drug crisis in the country’s history.
The Numbers Year by Year
Fentanyl-related deaths were relatively rare before 2014. The death rate from synthetic opioids (a CDC category dominated by fentanyl and its chemical cousins) was just 1.0 per 100,000 people in 2013. Then the numbers exploded. The rate nearly doubled every year for several years running: 1.8 in 2014, 3.1 in 2015, 6.2 in 2016. By 2017 it had reached 9.0, and it kept climbing through the pandemic to peak at 22.7 per 100,000 in 2022.
In raw numbers, synthetic opioid deaths rose from roughly 3,000 per year in 2013 to more than 70,000 per year by 2022 and 2023. That trajectory has only recently reversed. The 2024 count of 47,735 represents a 35.6% drop from 2023, the sharpest single-year decline since the crisis began. Provisional CDC data through mid-2025 shows the downward trend continuing, with a 12-month rolling count of about 39,261 fentanyl-involved deaths.
How Fentanyl Compares to Other Causes of Death
Even after the recent decline, fentanyl kills more Americans each year than car crashes or firearms. In 2024, motor vehicle traffic deaths totaled 41,241 and all firearm deaths totaled 44,447. Synthetic opioid deaths (47,735) exceeded both. At its 2022-2023 peak, fentanyl alone was killing nearly twice as many people as car accidents.
Fentanyl also dwarfs other drug threats. Heroin, once the face of the opioid epidemic, was involved in just 2,743 deaths in 2024. Fentanyl has essentially replaced heroin in the illicit drug supply while proving far more lethal.
Why Fentanyl Is So Deadly
Fentanyl is 50 times stronger than heroin and 100 times stronger than morphine. A dose of just 2 milligrams, roughly the weight of a few grains of salt, is considered potentially lethal. That extreme potency means tiny errors in manufacturing or mixing can turn a single pill or bag of powder into a fatal dose.
A major driver of the death toll is counterfeit pills. Illicit manufacturers press fentanyl into tablets designed to look like prescription painkillers or anti-anxiety medications. DEA lab testing has found that 7 out of every 10 counterfeit pills containing fentanyl carry a potentially lethal dose. People who believe they’re taking a pharmaceutical-grade pill may have no idea fentanyl is involved until it’s too late. Fentanyl also gets mixed into cocaine, methamphetamine, and other street drugs, catching users off guard.
The Economic Toll
The financial cost mirrors the human one. A CDC analysis estimated the total economic burden of the opioid epidemic at over $1 trillion in 2017 alone, when deaths were less than half of what they’d eventually reach. Fatal opioid overdoses accounted for $550 billion of that total, breaking down to roughly $11.5 million per death when factoring in lost productivity, healthcare costs, and the statistical value of a life lost. Lost productivity for each death was estimated at $1.4 million. With death counts far higher in the years that followed, the cumulative economic damage has been staggering.
Why Deaths Are Finally Dropping
The 35.6% decline from 2023 to 2024 is significant, though experts point to multiple factors rather than a single explanation. Wider distribution of naloxone (the overdose-reversing medication now available over the counter), expanded access to treatment for opioid addiction, law enforcement disruption of supply chains, and increased public awareness of counterfeit pill dangers have all played a role. Some researchers also note shifts in the drug supply itself, with certain markets seeing changes in what’s available on the street.
Still, 47,735 deaths in a single year is an enormous number. Even at its reduced 2024 level, fentanyl kills more than 130 Americans every day. The cumulative toll since the synthetic opioid wave began in 2013 likely exceeds 450,000 deaths, a figure comparable to the population of a mid-sized American city like Miami or Atlanta.